James Andrew Nathanielsz - Net Worth and Insider Trading

James Andrew Nathanielsz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Andrew Nathanielsz owns 1 companies in total, including Propanc Biopharma Inc (PPCB) .

Click here to see the complete history of James Andrew Nathanielsz’s form 4 insider trades.

Insider Ownership Summary of James Andrew Nathanielsz

Ticker Comapny Transaction Date Type of Owner
PPCB Propanc Biopharma Inc 2015-02-04 director & CEO & CFO & Secretary & Treasurer

James Andrew Nathanielsz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Andrew Nathanielsz Ownership Network

Ownership Network List of James Andrew Nathanielsz

No Data

Ownership Network Relation of James Andrew Nathanielsz


James Andrew Nathanielsz Owned Company Details

What does Propanc Biopharma Inc do?

Who are the key executives at Propanc Biopharma Inc?

James Andrew Nathanielsz is the director & CEO & CFO & Secretary & Treasurer of Propanc Biopharma Inc. Other key executives at Propanc Biopharma Inc include and CFO & Secretary Carlo M Campiciano .

Propanc Biopharma Inc (PPCB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Propanc Biopharma Inc (PPCB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Propanc Biopharma Inc (PPCB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Propanc Biopharma Inc (PPCB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Propanc Biopharma Inc Insider Transactions

No Available Data

James Andrew Nathanielsz Mailing Address

Above is the net worth, insider trading, and ownership report for James Andrew Nathanielsz. You might contact James Andrew Nathanielsz via mailing address: 1/76 Summerhill Road, Glen Iris, Victoria C3 3146.

Discussions on James Andrew Nathanielsz

No discussions yet.